| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |